Unquoted Biotechs Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Unquoted Biotechs

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (150)	10/2/2006 4:25:01 PM
From: dr.praveen	Read Replies (1) of 253

Antisoma says phase I cancer drug trials positive; phase II trials begin 2007 LONDON (AFX) - Antisoma PLC, the cancer drug maker, announced positive results from phase I tests on a range of cancers of one of its development drugs and said it plans phase II trials for the treatment in blood and renal cancer. The drug is a nucleic acid-based, so-called 'aptamer' treatment currently known as AS1411. 'Findings in renal cancer are particularly strong,' the company said. 'Antisoma will therefore proceed to a phase II trial in this indication. Antisoma will also initiate a phase II trial in a blood cancer indication. Both trials are expected to start in 2007.' Chief executive Glyn Edwards said: 'With these positive results, we intend to push the aptamer-based drug forward through parallel trials in renal and other cancers'.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next